Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease

United European Gastroenterol J. 2021 Oct;9(8):903-909. doi: 10.1002/ueg2.12150. Epub 2021 Oct 5.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent and potentially severe liver disease, emphasizing the need for implementation of widely supported care paths for patients at risk for advanced stages of NAFLD. In particular, the distinction of patients with a progressive and/or advanced, fibrotic NAFLD from those with simple steatosis requires improvement, as well as the awareness for NAFLD among health care professionals. Broad acceptance and implementation of interdisciplinary care paths in the near future will bring enhanced identification of those patients that benefit from surveillance, intensive lifestyle management, and empirical or investigational pharmacotherapy and enhance our epidemiological grasp of NAFLD in relation to lifestyle, genetic background, and cardiometabolic comorbidities related to NAFLD.

Keywords: care path; guideline; hepatology; liver fibrosis; non-alcoholic fatty liver disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Critical Pathways
  • Fibrosis
  • Humans
  • Liver / pathology*
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / epidemiology*
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / therapy
  • Practice Guidelines as Topic
  • Referral and Consultation